Chickens were fed 50 ppm [C-14]narasin rations. After 5 days, the chic
kens were sacrificed, and tissues were taken for assay. Tissues were a
ssayed for total radioactivity by solubilization and liquid scintillat
ion counting. The mean residue concentrations of narasin equivalents w
ere 0.32 ppm in liver, 0.12 ppm in fat, 0.08 ppm in skin/fat, 0.04 ppm
in kidney, and <0.04 ppm in muscle. Liver radioactivity was isolated
by liquid-liquid extractions and preparative silica liquid chromatogra
phy (LC). Radioactivity in fat was isolated and assayed by high-perfor
mance liquid chromatography/electrospray-mass spectrometry/liquid scin
tillation counting (HPLC/ESMS/LSC). The radioactivity in fat was chara
cterized as being predominately parent narasin. Excreta samples were a
lso collected for isolation, quantification, and characterization of n
arasin and its metabolites. Fifteen metabolites and parent narasin wer
e characterized from the excreta of chickens using HPLC/ESMS/LSC. Thes
e metabolites were predominately di- and trihydroxylated narasin and d
i- and trihydroxylated narasin B. These hydroxylated metabolites repre
sented almost 50% of the total radioactivity in excreta. The chromatog
raphic distribution and relative magnitude of radioactivity from liver
and excreta were similar, suggesting that excreta metabolites are the
same as those found in liver.